Cargando…
A Novel PEGylated Liposome-Encapsulated SANT75 Suppresses Tumor Growth through Inhibiting Hedgehog Signaling Pathway
The Hedgehog (Hh) pathway inhibitors have shown great promise in cancer therapeutics. SANT75, a novel compound we previously designed to specially inhibit the Smoothened (SMO) protein in the Hh pathway, has greater inhibitory potency than many of commonly used Hh inhibitors. However, preclinical stu...
Autores principales: | Yuan, Yike, Zhao, Yuwei, Xin, Shengchang, Wu, Ni, Wen, Jiaolin, Li, Song, Chen, Lijuan, Wei, Yuquan, Yang, Hanshuo, Lin, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613365/ https://www.ncbi.nlm.nih.gov/pubmed/23560085 http://dx.doi.org/10.1371/journal.pone.0060266 |
Ejemplares similares
-
Synthesis and characterization of Sant-75 derivatives as Hedgehog-pathway inhibitors
por: Che, Chao, et al.
Publicado: (2012) -
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
por: Najlah, Mohammad, et al.
Publicado: (2019) -
Pegylated liposomal-encapsulated doxorubicin in cutaneous composite lymphoma: A case report
por: Wollina, Uwe, et al.
Publicado: (2016) -
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated (188)Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor
por: Lin, Bing-Ze, et al.
Publicado: (2020) -
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023)